Genomic comparison of carbapenem-resistant Enterobacteriaceae from humans and gulls in Alaska

J Glob Antimicrob Resist. 2021 Jun;25:23-25. doi: 10.1016/j.jgar.2021.02.028. Epub 2021 Mar 2.

Abstract

Objectives: Wildlife may harbour clinically important antimicrobial-resistant bacteria, but the role of wildlife in the epidemiology of antimicrobial-resistant bacterial infections in humans is largely unknown. In this study, we aimed to assess dissemination of the blaKPC carbapenemase gene among humans and gulls in Alaska.

Methods: We performed whole-genome sequencing to determine the genetic context of blaKPC in bacterial isolates from all four human carbapenemase-producing Enterobacteriaceae (CPE) infections reported in Alaska between 2013-2018 and to compare the sequences with seven previously reported CPE isolates from gull faeces within the same region and time period.

Results: Genomic analysis of CPE isolates suggested independent acquisition events among humans with no evidence for direct transmission of blaKPC between people and gulls. However, some isolates shared conserved genetic elements surrounding blaKPC, suggesting possible exchange between species.

Conclusion: Our results highlight the genomic plasticity associated with blaKPC and demonstrate that sampling of wildlife may be useful for identifying clinically relevant antimicrobial resistance not observed through local passive surveillance in humans.

Keywords: Antimicrobial resistance; Carbapenem resistance; Molecular epidemiology; One Health; bla(KPC).

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Alaska / epidemiology
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Carbapenem-Resistant Enterobacteriaceae*
  • Charadriiformes*
  • Enterobacteriaceae Infections* / epidemiology
  • Genomics
  • Humans

Substances

  • Anti-Bacterial Agents